COLLIDEM

Welcome to the Brand page for “COLLIDEM”, which is offered here for Chemical products for biomedical research and therapy, cellular preparations for cancer immunotherapy; pharmaceutical products for biomedical research and therapy, cell products for biomedical research and therapy; culture media, cells and cellular cultures for biomedical research and therapy, for cellular in vivo and ex vivo immunotherapy, in particular for anti-cancer immunotherapy;.

Its status is currently believed to be active. Its class is unavailable. “COLLIDEM” is believed to be currently owned by “I.D.M. IMMUNO-DESIGNED MOLECULES”.